Arcus Biosciences Prices $250 Million Common Stock Offering
Arcus Biosciences announced pricing of an underwritten public offering of 14,285,715 shares of common stock.
Story updates
02:53:38 AM UTC
SquawkNews
Arcus Biosciences priced 14,285,715 shares at $17.50 per share for expected gross proceeds of $250.0M. Underwriters have a 30-day option for up to 2,142,857 additional shares. Closing is expected Oct. 23, 2026, subject to customary conditions.Material DetailsContext by AI AnalystThis is a late-clin…
02:58:31 AM UTC
SquawkNews
Arcus Biosciences Prices Underwritten Public Offering of 14.3M Shares at $17.50 Per Share>RCUS
02:58:40 AM UTC
SquawkNews
Arcus Biosciences: Offering Expected to Close Oct. 23 >RCUS
Arcus Biosciences, Inc. (NYSE:RCUS), a late clinical-stage biopharmaceutical company focused on developing differentiated molecules and combinations for the treatment of cancer and immune diseases, today announced the pricing of an underwritten public offering of 14,285,715 shares of its common sto…